SAN DIEGO, June 15, 2021 /PRNewswire/ -- Prometheus Laboratories, Inc. ("Prometheus"), a leader in precision healthcare, announces the execution of an agreement with MultiPlan, a trusted partner to ...
The San Diego-based pharmaceutical company Prometheus Laboratories has launched PROMETHEUS Anser VDZ, a monitoring test for inflammatory bowel disease patients using vedolizumab. 1. The PROMETHEUS ...
PredictrPK ® ADA addresses the unmet need for individualized optimization of adalimumab (ADA) therapy in support of sustained clinical remission and drug persistence. SAN DIEGO, CA / ACCESSWIRE / July ...
PredictrPK IFX is now available for both the induction and maintenance phases of infliximab (IFX) therapy for inflammatory bowel disease (IBD) patients PredictrPK IFX addresses the unmet need of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results